Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

01 December 2007

Pharmacokinetics of mycophenolic acid and its phenyl-glucuronide in kidney transplant recipients with renal insufficiency

M. Chrzanowska, J. Kamińska, M. Głyda, N. Wachowiak

Ann Transplant 2008; 13(1): 40-40 :: ID: 880204


Background: The aim of the study was to analyze the influence of renal insufficiency on the pharmacokinetics of mycophenolic acid (MPA) and its glucuronide metabolite (MPAG) in kidney transplant patients.
Material/Methods: The study included 43 adult patients at least one year after renal transplantation (from 1 to 11 years), treated with mycophenolate mofetil (MMF) and tacrolimus or cyclosporine and steroids. They were divided into a group with normal renal function (n=16; creatinine clearance [Cl[sub]cr[/sub]] >60 ml/min) and one with renal insufficiency (n=27, Cl[sub]cr[/sub]<60 ml/min). Areas under the 4-hour curve (AUC[sub]0-4h[/sub]) of MPA and MPAG were determined using a validated HPLC method.
Results: The renal insuffi ciency group showed significantly increased AUC[sub]0-4[/sub] and trough levels for MPAG (543.1±366.1 vs. 273.9±113.2 mg-h/ml, p=0.002, and 106.0±78.5 vs. 42.8±22.5 mg/ml, p=0.0002, respectively) and increased trough level of MPA (p=0.01). There was a significant correlation between MPAG AUC[sub]0-4[/sub] or C[sub]0[/sub] and Cl[sub]cr[/sub] (r=±0.592, p<0.00001 and r=-0.698, p<0.00001, respectively). There was no significant difference in MPA AUC[sub]0-4 [/sub]between the renal insufficiency and the normal renal function groups.
Conclusions: Although MPAG is an inactive metabolite, its accumulation in patients with renal impairment can be unfavorable. MPAG has been shown to displace MPA from protein binding sites increasing MPA free fraction without changing total MPA AUC. This should be taken into account when deciding upon MMF dose in patients with renal failure with unexpected side effects.

Keywords: Pharmacokinetics, Mycophenolic Acid, renal transplantation, Tacrolimus


Most Viewed Current Articles

26 Jan 2022 : Review article  

Recurrence of Hepatocellular Carcinoma After Liver Transplantation: Risk Factors and Predictive Models

DOI :10.12659/AOT.934924

Ann Transplant 2022; 27:e934924

24 Aug 2021 : Review article  

Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future Perspectives

DOI :10.12659/AOT.931664

Ann Transplant 2021; 26:e931664

29 Dec 2021 : Original article  

Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...

DOI :10.12659/AOT.933588

Ann Transplant 2021; 26:e933588

15 Mar 2022 : Case report  

Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...

DOI :10.12659/AOT.935860

Ann Transplant 2022; 27:e935860

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358